The Food Safety and Standards Authority of India has initiated legal action against Nestle India for alleged regulatory violations involving marketing practices and substandard nutritional content in infant products.
Reader brief
Through the Reader lens: The Food Safety and Standards Authority of India has filed three adjudication cases against Nestle India following investigations into infant formula products. The regulator alleged that the company violated regulations by using promotional claims for NAN Excella Pro Stage 1 and Lactogen Pro 1 that are prohibited for infant nutrition. Additionally, laboratory tests confirmed that a follow-up formula manufactured by the company failed to meet the prescribed standards for biotin content.
What to watch next
- Outcome of the three adjudication cases filed against Nestle India
- Response from Nestle India regarding the allegations
- Potential regulatory changes or increased scrutiny on infant food marketing
Sources1
All filed from IndiaNamed India · Lactogen Pro 1 · NAN Excella Pro Stage 1 · Nestle India · Food Safety and Standards Authority of India
- [1]The Times of IndianeutralFSSAI flags Nestle infant products over false promotional claims, biotin levels